- Home
- BANX vs CATX Comparison
BANX vs CATX Comparison
Compare BANX & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BANX | CATX |
|---|---|---|
| Founded | 2013 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.8M | 162.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BANX | CATX |
|---|---|---|
| Price | $21.66 | $2.40 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $11.56 |
| AVG Volume (30 Days) | 23.4K | ★ 2.0M |
| Earning Date | 06-17-2025 | 11-10-2025 |
| Dividend Yield | ★ 9.66% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.35 | N/A |
| Revenue | ★ $29,467,794.00 | $1,075,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $8.88 | ★ N/A |
| Revenue Growth | ★ 2.73 | N/A |
| 52 Week Low | $17.99 | $1.60 |
| 52 Week High | $21.67 | $5.39 |
Technical Indicators
Market Signals| Indicator | BANX | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 49.54 | 48.74 |
| Support Level | $21.01 | $2.07 |
| Resistance Level | $22.30 | $2.39 |
| Average True Range (ATR) | 0.33 | 0.20 |
| MACD | 0.02 | 0.07 |
| Stochastic Oscillator | 36.13 | 75.13 |
Price Performance
Historical ComparisonAbout BANX ArrowMark Financial Corp.
ArrowMark Financial Corp is a non-diversified, closed-end management investment company. Its objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds and others.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.